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ARTICLE OPEN ACCESS CLASS OF EVIDENCE
Specialized Outpatient Clinic vs Stroke Unit for
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To evaluate the effects of an outpatient clinic setup for minor stroke/TIA using subsequent
admission of patients at high risk of recurrent stroke.
Methods
We performed a cohort study of all patients with suspected minor stroke/TIA seen in an
outpatient clinic at Aarhus University Hospital, Denmark, between September 2013 and Au-
gust 2014. Patients with stroke were compared to historic (same hospital) and contemporary
(another comparable hospital) matched, hospitalized controls on nonprioritized outcomes:
length of stay, readmissions, care quality (10 process–performance measures), and mortality.
Patients with TIA were compared to contemporary matched, hospitalized controls. Following
complete diagnostic workup, patients with stroke/TIA were classified into low/high risk of
recurrent stroke ≤7 days.
Results
We analyzed 1,076 consecutive patients, of whom 253 (23.5%) were subsequently admitted to
the stroke ward. Stroke/TIA was diagnosed in 215/171 patients, respectively. Fifty-six percent
(121/215) of the patients with stroke were subsequently admitted to the stroke ward. Com-
parison with the historic stroke cohort (n = 191) showed a shorter acute hospital stay for the
strokes (median 1 vs 3 days; adjusted length of stay ratio 0.49; 95% confidence interval
0.33–0.71). Thirty-day readmission rate was 3.2% vs 11.6% (adjusted hazard ratio 0.23
[0.09–0.59]), and care quality was higher, with a risk ratio of 1.30 (1.15–1.47). The comparison
of stroke and TIAs to contemporary controls showed similar results. Only one patient in the
low risk category and not admitted experienced stroke within 7 days (0.6%).
Conclusions
An outpatient clinic setup for patients with minor stroke/TIA yields shorter acute hospital stay,
lower readmission rates, and better quality than hospitalization in stroke units.
Classification of Evidence
This study provides Class III evidence that a neurovascular specialist–driven outpatient clinic
for patients with minor stroke/TIA with the ability of subsequent admission is safe and yields
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Patients with minor stroke/TIA are at high risk of a recurrent
ischemic event,1,2 but landmark studies show a dramatic effect
of immediate hospital referral.3,4 It has long been known that
patients in an organized inpatient stroke unit fare better than
those in a general ward,5,6 and it is feasible and cost-effective
to handle most minor strokes and TIAs in specialized acute
outpatient clinics.4,7–11 However, we do not know how acute
outpatient specialist care compares with in-hospital stroke
unit care.12,13 It is debated how to most efficiently organize
services for patients with minor stroke/TIA12,14–16 and use of
hospitalization seems widespread.17,18 Hospitalization confers
theoretical benefits over urgent outpatient clinic referral in-
cluding monitoring of the patients and rapid access to re-
vascularization, but these benefits are offset by potential
drawbacks of hospitalization together with potential overuse
of hospital resources.12,14,19,20 The risk of a recurrent stroke
remains the main concern of outpatient treatment and an
innovative approach may be a hybrid that combines benefits
from both strategies.14
In 2012, an acute outpatient clinic for patients with suspected
minor stroke/TIA opened at Aarhus University Hospital,
Denmark, following centralization of acute stroke care
services.21,22 In the clinic, a specialized neurovascular team
performs a complete diagnostic workup and treatment the
same day the patient is referred and assesses the risk of pa-
tients with stroke/TIA to identify those at high risk of a re-
current stroke and hence eligible for admission to a regular
stroke ward.
Methods
Standard Protocol Approvals, Registrations,
and Patient Consents
The study was approved by the Danish Data Protection
Agency (2012-58-006), the Danish Patient Safety Authority
(3-3013-1878/1), and the Danish Clinical Registries. Under
Danish law, registry-based studies require no ethics approval
or patient consent. The Danish Patient Safety permitted
collection of information from the patient records without
patients’ consent.
Primary Research Question and Classification
of Level of Evidence
The primary research question was as follows: Is an outpatient
clinic setup for patients with minor stroke/TIA combined
with admission of selected high risk patients effective and safe
compared to stroke unit admission of all patients with minor
stroke/TIA?
This study provides Class III evidence that an outpatient clinic
setup for minor stroke/TIA with subsequent admission of
patients at high risk of a recurrent stroke yields shorter acute
hospital stay, lower readmission rates, and better quality than
hospitalization in stroke units.
Outpatient Clinic Setup and Risk Assessment
The outpatient clinic at Aarhus University Hospital, Den-
mark, is part of 1 of the 2 high-volume designated stroke
centers that receive all patients with acute stroke and TIA
from the Central Denmark Region (CDR) (1.3 million in-
habitants).22 The outpatient clinic is an integrated part of the
stroke unit, which is open 7 days a week in the daytime (8
AM–6 PM) and staffed by a specialized neurovascular senior
doctor, a nurse, and therapists when needed.
A local stroke guideline was developed for all patients with
suspected acute stroke and TIA with symptom onset within
the past 7 days and 48 hours, respectively, or accumulated
neurovascular episodes. According to this guideline, the pre-
hospital service or general practitioners immediately called an
experienced neurologist on call 24 hours/7 days to arrange
acute evaluation by stroke specialist. All self-reliant patients
with suspected acute minor stroke who were not candidates
for acute reperfusion or TIA were seen in the outpatient clinic
during opening hours. At nighttime, these patients were ad-
mitted for immediate evaluation in the stroke unit. The
emergency department was bypassed in all cases. Figure 1
shows the details of the patient flow.
Diagnostic workup in the outpatient clinic included a brain
scan (standard MRI), ultrasound of carotid arteries (if in-
dicated, ultrasound, CT angiography, or magnetic resonance
angiography of the intracranial vessels), blood samples,
ECG, and evaluation of lifestyle factors. If a Holter monitor
was indicated, the patient was provided one as an outpatient
and could return the equipment by mail. If the patient
needed echocardiography, he or she was referred to the
Department of Cardiology. All patients in need of outpatient
rehabilitation had a full evaluation by a physiotherapist and
an occupational therapist before returning home, and had a
plan for outpatient rehabilitation by community service.
Patients in whom thrombolysis or thrombectomy was in-
dicated were handed over to staff in the stroke unit as the
outpatient clinic was part of the acute stroke center and
located in the same facilities.
After the outpatient evaluation, we systematically assessed risk
in all patients diagnosed with stroke or TIA to distinguish
Glossary
CDR = Central Denmark Region;CI = confidence interval;DSR =Danish Stroke Registry;DWI = diffusion-weighted imaging;
HR = hazard ratio; ICH = intracerebral hemorrhage; LOSR = length of stay ratio;NIHSS = NIH Stroke Scale; RR = risk ratio;
SSS = Scandinavian Stroke Scale.
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between those at low risk of a recurrent stroke within 7 days
who could safely be sent directly home from those at high risk
of a recurrent stroke who may need to be admitted to the
stroke ward. For risk assessment, we used a tool developed by
the neurovascular team. The tool included the ABCD2
score23–25 and results of imaging of the brain and precranial or
intracranial arteries26,27 together with other risk factors, for
example, cardioembolic risk factors. At the neurologist’s dis-
cretion, other elements like psychosocial issues were taken
into account. For patients with stroke, the tool included the
NIH Stroke Scale (NIHSS) score28 instead of the ABCD2
score. The risk assessment was a guiding tool only; the final
decision to admit the patient to the stroke unit was made at
the specialized neurovascular senior doctor’s discretion.
If the patient with stroke/TIA was sent home directly from
the outpatient clinic, we rang the patient on day 7 to identify
any new vascular events.
In patients without a cerebrovascular diagnosis, staff in the
outpatient clinic finished the diagnostic workup, performing
other relevant tests or procedures, for example, lumbar
puncture or other neuroradiologic examinations. The patient
was admitted to the general neurologic ward for further in-
vestigations only in case of a suspected or confirmed major
neurologic disease (e.g., tumor). Furthermore, we assessed
patients with non-neurologic disease to determine whether
they needed admission at another hospital department or
could be sent home to follow up with a general practitioner.
Study Design
This was a cohort study. The effects of the outpatient clinic
setup in patients with minor stroke/TIA were investigated by
comparing outcomes to those of matched controls.
Study Cohort and Matched Controls
The outpatient clinic cohort included all patients with sus-
pected minor stroke or TIA evaluated in the acute neuro-
vascular outpatient clinic at Aarhus University Hospital,
Denmark, between 1 September 2013 and 31 August 2014,
including patients who ended up being admitted at the stroke
ward or converted to an IV thrombolysis pathway.
Patients with minor strokes were compared to 2 reference
populations, including historic and contemporary matched,
hospitalized controls, respectively. Patients with TIA were
compared to contemporary matched, hospitalized controls
only as historic controls were not available in the Danish
Stroke Registry (DSR).
Figure 2 shows the details of how we generated the matched
historic stroke cohort from the same hospital between May
2011 and April 2012, that is, before the outpatient clinic was
established, and the contemporary stroke and TIA cohort
from a comparable stroke center at a university hospital in the
Capital Region (Glostrup) without an acute outpatient clinic
service. Before matching the 2 cohorts, we restricted the pa-
tient populations to patients with reliable data on length of
acute hospital stay, known vital status, and complete
Figure 1 Details of the Triage of Patients With Suspected Stroke/TIA (Symptom Onset <7 Days/48 Hours) in the Central
Denmark Region in the Study Period
EMS = emergency medical services; GP = general practitioner.
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information on matching criteria: age (groups: 0–18, 19–50,
51–65, 66–80, 80+ years), sex, stroke severity (Scandinavian
Stroke Scale [SSS] in groups: 0–14, 15–29, 30–44, 45–58),
treatment with thrombolysis including door-to-needle time
(under or above 1 hour), and subtype of diagnosis (ischemic
stroke, ICH, or TIA). The matching was done 1:1, and pa-
tients from the reference cohorts could be used more than
once.
Outcomes
The complete study cohort was investigated with regards to
the distribution of “neurovascular diagnosis,” “neurologic di-
agnosis,” and “non-neurologic diagnosis,” and the most
common diagnoses within each subgroup were identified.
Furthermore, we estimated the rates of patients with sub-
sequent admission at the stroke ward. In patients with is-
chemic stroke/TIA, we estimated the rates of low risk and
high risk according to the risk assessment tool. The rate of
recurrent vascular events within 7 days was examined in pa-
tients with stroke or TIA discharged directly from the out-
patient clinic.
The effects of the outpatient clinic setup were investigated in
patients with stroke using the following nonprioritized out-
come measures: length of acute and total (including in-
hospital rehabilitation) hospital stay, all-cause bed days, hos-
pital readmissions after discharge (0–30 and 31–365 days),
mortality (0–30 and 0–365 days), and quality of care (10
individual key process performance measures).
The patients with TIA were evaluated according to the same
outcome measures except for readmissions and all-cause bed
days as these data were not available and only 4 of the in-
dividual key process performance measures were found to be
relevant for TIA and were therefore included.
We defined 2 composite measures of process quality of care:
the “all or none” measure was defined as the proportion of
minor stroke/TIA episodes where all eligible measures were
fulfilled for the individual patient, whereas the “opportunity-
based” score was defined as the overall proportion of fulfilled
relevant performance measures for each patient. The latter
score was calculated by dividing the total number of received
processes for each patient by the total number of processes for
which the patient was considered eligible.
We recorded the number of patients with TIA with acute
lesions on MRI (diffusion-weighted imaging [DWI]–
positive) or infarction on CT.
Definitions
A suspected acute stroke (or TIA) was defined as acute focal
neurologic deficits (or a history of such disease) with no other
obvious reasons than a possible cerebrovascular event. Stroke
was defined as symptoms of vascular origin lasting 24 hours or
longer or leading to death, and included ischemic strokes and
intracerebral hemorrhages (ICH). TIA was defined as a tran-
sient episode of neurologic symptoms of ischemic origin lasting
less than 24 hours, disregardingMRI confirmation, but TIA did
not include related syndromes, for example, amaurosis fugax.
Admission length was counted as half rather than whole days
when a patient died or went home from the hospital on the
day of evaluation. To ensure that the total length of the
hospital stay included rehabilitation irrespective of local or-
ganizational differences, admissions on the day following the
end of the acute stay were calculated as part of the total stay.
All-cause bed days were defined as the total number of days spent
in the hospital within the first year, including the total hospital stay
of the initial stroke admission. To ensure that outpatient visits
Figure 2 Details of Generation of the Matched Historic Stroke Cohort and the Matched Contemporary Stroke and TIA
Cohorts
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were not counted as part of all-cause bed days, only new admis-
sions (acute/nonacute) of ≥24 hours were included.
To be considered a readmission, at least 1 day was required
between the day of the termination of the total stay and the
next admission date. Only acute admissions ≥24 hours were
included; hence, no outpatient visits were considered read-
missions. All admissions due to carotid artery surgery were
excluded as readmissions because they were considered part
of the acute stroke care.
To be classified as being at low risk, patients with TIA would
have to have no acute ischemia on MRI (DWI/infarction on
CT) or an ABCD2 score ≤3 and patients with stroke an
NIHSS score <5. Furthermore, patients with TIA and stroke
should have no symptomatic stenosis (≥50%) of the carotid
arteries, no symptomatic stenosis (verified or suspected) of
the intracranial vessels, no major cardioembolic risk factors,
and no other complications for which an inpatient course was
needed.
Data Sources
A local registry holds information on diagnosis for all patients
(vascular or nonvascular), including imaging and risk assess-
ment, and it includes the mandatory process and outcome
indicators collected in the DSR.29,30 This local registry in-
cludes results of 7-day follow-up. Local registration was
completed on a daily basis by the clinic’s neurovascular team.
The electronic medical records were searched in case of
missing information on risk assessment or vascular events
within 7 days.
We obtained data from the DSR (baseline characteristics,
length of acute hospital stay, and process performance mea-
sures) to characterize strokes and TIA from the study cohort
and the matched cohorts. Reporting to the DSR is mandatory
for all acute strokes (≥18 years of age) seen at hospitals. Given
the Danish tradition for seeing almost all patients with acute
stroke symptoms in the hospital, almost all patients with acute
stroke in Denmark are registered.31 The completeness of
stroke event registration in the DSR exceeds 90%.32
The Danish National Patient Register provided information on
subsequent hospitalizations, including transfers from the acute
stroke unit to in-hospital rehabilitation and readmissions.33
The Danish Civil Registration System provided information
on patients’ vital status.34 This system assigns a unique per-
sonal identification number to all Danish citizens, and we used
this to link information recorded in different databases.
Statistical Analysis
We used a generalized linear model with a log-link and gamma
distribution family to compare the length of stay ratios
(LOSRs).
For readmissions, we compared hazard ratios (HRs) using
multivariable Cox regression encountering the time of a po-
tential readmission or death and analyzed mortality outcomes
accordingly. We also calculated adjusted and unadjusted HRs.
We analyzed clinical guideline-recommended process per-
formance measures using binomial regression. Unadjusted
risk ratios (RRs) were calculated. We included only cases
where the health professionals caring for the individual patient
had judged the specific process measure to be relevant.
By using multivariable models, we adjusted for age (contin-
uous variable), living arrangement, previous stroke, diabetes,
atrial fibrillation, hypertension, smoking habits, alcohol use,
and stroke severity (SSS as a continuous variable). Unknown
or missing information on living arrangement, previous
stroke, diabetes, atrial fibrillation, hypertension, smoking
habits, and alcohol use was encoded by an indicator variable
and included in the adjusted analyses. Confidence intervals
(CIs) were based on robust standard errors.
We used the Stata 13.0 package (StataCorp LP, College
Station, TX) for all analyses.
Data Availability
According toDanish law, it is not possible to provide public access
to a dataset that is based on linkage of data fromnationwide public
registries. Access to Danish registry data can be granted to in-
dividual researchers only upon seeking approval from theNational
Agency forData Protection.We therefore cannot place the dataset
in a public repository. However, pooling of aggregated data is
possible and would be of interest to the research group.
Results
The outpatient clinic cohort comprised 1,076 patients (figure
2), of whom 253 (23.5%) were subsequently admitted to the
stroke unit. A neurovascular diagnosis was given in 510 of the
patients (47.4%). Of these, 215 had a stroke, 171 had TIA,
Table 1 Risk Category on all Patients With Ischemic
Stroke and TIA From the Outpatient Clinic Cohort
and Information on Any Subsequent Admission
to the Stroke Ward, n (%)
Ischemic stroke and TIA,
n = 382
High-risk
category, n = 167
Low-risk category,
n = 215
Admitted to stroke ward 122 (73.1) 45 (20.9)
Stayed as outpatient 45 (26.9) 170 (79.1)
7-day follow-up:
recurrent eventsa
1 (2.2)b 1 (0.6)c
a Results of 7-day follow-up for recurrent vascular events (recurrent TIA,
stroke, or acute myocardial infarction) in the outpatients without admission
to stroke ward.
b Recurrent TIA.
c Recurrent ischemic stroke.
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Table 2 Characteristics of the Patients From the Matched Cohorts: Outpatient Stroke Cohort 1 (OSC1) vs Historic Stroke
Cohort (HSC), Outpatient Stroke Cohort 2 (OSC2) vs Contemporary Stroke Cohort (CSC), and Outpatient TIA
Cohort (OTC) vs Contemporary TIA Cohort (CTC)
OSC1 HSC OSC2 CSC OTC CTC
Patients, n 191 191 194 194 153 153
Age, y, mean (SD) 65.8 (11.8) 66.3 (13.2) 65.5 (12.0) 66.0 (12.9) 66.3 (13.2) 67.4 (13.3)
Sex, female, n (%) 76 (39.8) 76 (39.8) 79 (40.7) 79 (40.7) 69 (45.1) 69 (45.1)
Severity, SSS score, median (IQR) 56 (3) 55 (9) 56 (3) 56 (5) 58 (0) 58 (2)
Thrombolysis, n (%) 3 (1.6) 3 (1.6) 3 (1.6) 3 (1.6) 0 (0.0) 0 (0.0)
Days to evaluation, median (IQR) 1 (2) 1 (1) 1 (2) 1 (2) 0 (1) 0 (0)
Unknown/missing, n (%) 0 (0.0) 2 (1.0) 0 (0.0) 9 (4.6) 0 (0.0) 3 (2.0)
Subtype, n (%)
Intracerebral hemorrhage 4 (2.1) 4 (2.1) 3 (1.6) 3 (1.6) NA NA
Ischemic stroke 187 (97.9) 187 (97.9) 191 (98.5) 191 (98.5) NA NA
TIA NA NA NA NA 153 (100.0) 153 (100.0)
Former stroke, n (%)
Yes 45 (23.6) 44 (23.0) 45 (23.2) 45 (23.2) 18 (11.8) 38 (24.8)
No 146 (76.4) 146 (76.4) 149 (76.8) 148 (76.3) 135 (88.2) 115 (75.2)
Unknown/missing 0 (0.0) 1 (0.5) 0 (0.0) 1 (0.5) 0 (0.0) 0 (0.0)
Hypertension, n (%)
Yes 115 (60.2) 104 (54.5) 118 (60.8) 106 (54.6) 72 (47.1) 76 (49.7)
No 75 (39.3) 82 (42.9) 75 (38.7) 85 (43.8) 80 (52.3) 77 (50.3)
Unknown/missing 1 (0.5) 5 (2.6) 1 (0.5) 3 (1.55) 1 (0.7) 0 (0.0)
Diabetes, n (%)
Yes 23 (12.0) 21 (11.0) 25 (13.0) 26 (13.4) 20 (13.1) 27 (17.7)
No 168 (88.0) 167 (87.4) 169 (87.1) 167 (86.1) 132 (86.3) 126 (82.4)
Unknown/missing 0 (0.0) 3 (1.6) 0 (0.0) 1 (0.5) 1 (0.7) 0 (0.0)
Atrial fibrillation, n (%)
Yes 11 (5.8) 26 (13.6) 11 (5.7) 28 (14.4) 15 (9.8) 16 (10.5)
No 180 (94.2) 163 (85.3) 183 (94.3) 163 (84.0) 138 (90.2) 135 (88.2)
Unknown/missing 0 (0.0) 2 (1.1) 0 (0.0) 3 (1.6) 0 (0.0) 2 (1.3)
Alcohol use, n (%)
≤14 (F)/21 (M) units per week 161 (84.3) 158 (82.7) 163 (84.0) 154 (79.4) 135 (88.2) 130 (85.0)
>14 (F)/21 (M) units per week 29 (15.2) 29 (15.2) 30 (15.5) 32 (16.5) 17 (11.1) 18 (11.8)
Unknown/missing 1 (0.5) 4 (2.1) 1 (0.5) 8 (4.1) 1 (0.7) 5 (3.3)
Smoking, n (%)
Daily 86 (45.03) 74 (38.7) 88 (45.4) 69 (35.6) 29 (19.0) 32 (20.9)
Former 56 (29.32) 56 (29.3) 56 (28.9) 51 (26.3) 51 (33.3) 57 (37.3)
Never 49 (25.65) 61 (31.9) 50 (25.8) 61 (31.4) 71 (46.4) 53 (34.6)
Unknown/missing 0 (0.00) 0 (0.00) 0 (0.0) 13 (6.7) 2 (1.3) 11 (7.2)
Continued
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and 124 had another neurovascular diagnosis. Ninety-four
(43.7%) of the patients with stroke and 121 (70.8%) of the
patients with TIA were sent directly home from the outpatient
clinic; of these, 170 (79.1%) were considered low-risk patients
(table 1). Of the 690 patients with another neurovascular
diagnosis (n = 124) (not stroke or TIA) or a non-
neurovascular diagnosis (n = 566), 608 (88.1%) were man-
aged without subsequent admission to the stroke ward.
Of the 124 patients with another neurovascular diagnosis, the 3
most common diagnoses were amaurosis fugax/retinal artery
occlusion (n = 65), recrudescence of prior stroke (n = 35), and
subdural hemorrhage (n = 6). A large percentage (43.6%) were
registered with another neurologic diagnosis (n = 469) and the
3 most common diagnosis among these were disturbances of
skin sensation (n = 112), migraine (n = 62), and dizziness (n =
57). A non-neurologic diagnosis was given in only 97 (9%) of
the patients from the outpatient clinic cohort and the 3 most
common diagnoses were syncope and collapse (n = 21),
noncentral disorders of vestibular function (n = 12), and in-
fections (e.g., cystitis, sinusitis, meningitis) (n = 9).
We obtained complete risk assessment score data on all 382
patients with ischemic stroke and TIA from the outpatient
clinic cohort. Of the 170 patients at low risk handled as out-
patients without subsequent admission to the stroke unit, only
one had a recurrent stroke (0.6%) within the first 7 days after
the outpatient visit (table 1).
Three patients with ischemic stroke from the study cohort
received thrombolysis; all 3 were treated within 1 hour from
arrival to the outpatient clinic.
Of the patients with TIA, 33 (19.3%) had an acute lesion on
MRI (DWI-positive) or an infarction on CT, whereas this was
the case for 187 (88.6%) of the patients with ischemic stroke.
Approximately 90% of the patients with stroke and TIA were
available for comparison with the matched reference pop-
ulations after we had excluded those who were not eligible or
matched. Figure 2 shows details of generation of the matched
historic stroke cohort and the matched contemporary stroke
and TIA cohorts.
The baseline characteristics of the matched stroke and TIA co-
horts are shown in table 2. Overall, the groups were well bal-
anced with regard to age (stroke/TIA ≈66–67 years) and stroke
severity (stroke ≈55–56 of 58 points on the SSS). The median
number of days from symptom onset to admission was the same,
with a median of 1 day in the stroke cohorts and 0 days in the
TIA cohorts.
Patients with stroke from the study cohort (n = 191) had a
shorter risk-adjusted length of acute hospital stay than the his-
toric stroke cohort (n = 191) (median 1 vs 3 days; adjusted
LOSR 0.49 [95% CI 0.33–0.71]) (table 3). Furthermore, the
length of total stay including rehabilitation was shorter in the
strokes from the study cohort than in the historic cohort (me-
dian 1 vs 4 days; adjusted LOSR 0.57 [95% CI 0.36–0.89]) and
all-cause bed days within the first year were fewer (median 2 vs 6
days; adjusted LOSR 0.67 [0.46–1.00]). Moreover, in this
comparison of strokes from the outpatient clinic cohort with
historic controls, readmission rates within the first 30 days after
the initial hospital stay were lower (3.2% vs 11.6%; adjusted HR
0.23 [0.09–0.59]), whereas risk-adjusted readmission rates be-
tween days 31 and 365 were comparable. Mortality rates at day
30 and day 365 were equal and low (0.0% vs 0.5%; 2.6% vs
5.2%). All or none of 10 process performance measures were
higher in the patients with stroke from the outpatient clinic
cohort (84.3%) than among patients with stroke in the historic
stroke cohort (64.9%) with an RR of 1.30 (1.15–1.47) (table 3).
The comparison of the patients with stroke from the outpatient
clinic cohort (n = 194) with the patients with strokes from the
matched contemporary cohort from Glostrup (n = 194)
showed almost the same picture, with a shorter median acute
hospital stay (1 vs 4 days), fewer readmissions in the first 30
days (3.1 vs 11.3%), comparable mortality rates, and higher all
or none of 10 process performance measures (table 4).
Patients with TIA from the outpatient clinic cohort were
compared with the matched contemporary TIA cohort from
Table 2 Characteristics of the Patients From the Matched Cohorts: Outpatient Stroke Cohort 1 (OSC1) vs Historic Stroke
Cohort (HSC), Outpatient Stroke Cohort 2 (OSC2) vs Contemporary Stroke Cohort (CSC), andOutpatient TIA Cohort
(OTC) vs Contemporary TIA Cohort (CTC) (continued)
OSC1 HSC OSC2 CSC OTC CTC
Living arrangements, n (%)
Living with someone 125 (65.5) 124 (64.9) 127 (65.5) 116 (59.8) 104 (67.9) 94 (61.4)
Living alone 65 (34.0) 66 (34.6) 66 (34.0) 73 (37.6) 49 (32.0) 52 (34.0)
Other form 1 (0.5) 1 (0.5) 1 (0.5) 3 (1.6) 0 (0.0) 3 (2.0)
Unknown/missing 0 (0.0) 0 (0.0) 0 (0.0) 2 (1.0) 0 (0.0) 4 (2.6)
Abbreviations: IQR = interquartile range; SSS = Scandinavian Stroke Scale.
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Table 3 Differences in Lengths of Hospital Stay, All-Cause Bed Days, Readmissions, Mortality, and Process Performance
Measures in Outpatient Stroke Cohort 1 (OSC1) and the Matched Historic Stroke Cohort (HSC)
Bed days (in hospital)
Outpatient stroke 1 (OSC1), n = 191/215,
d, median (IQR)
Historic stroke (HSC), n = 191,
d, median (IQR)

















Outpatient stroke 1 (OSC1), n = 191/215, %
(CI), n/total n










Admitted to stroke unit 3.6 (0.1–7.1), 4/112 NA NA NA
Outpatient course only 2.6 (−1.0-6.2), 2/77 NA NA NA




Admitted to stroke unit 26.8 (18.5–35.1), 30/112 NA NA NA
Outpatient course only 29.9 (19.4–40.3), 23/77 NA NA NA
Mortality
Outpatient stroke 1 (OSC1), n =
191/215, % (CI), n/total n






30 days 0.0 (0.0–0.0), 0/191 0.5 (−0.5 to 1.6), 1/191 NA NA






Outpatient stroke 1 (OSC1), n = 191/215,
% (CI), n/total n
Historic stroke (HSC), n = 191,




















66.7 (28.2–105.1), 6/9 100.0 (100.0–100.0), 9/9 0.64
(0.40–1.01)
NA
Brain imaging (CT or MRI)
≤0 daysd
98.4 (96.7–100.2), 188/191 93.2 (89.6–96.8), 178/191 1.06
(1.01–1.10)
NA
Imaging of the carotids ≤4
daysd
99.4 (98.2–100.6), 168/169 91.4 (87.0–95.9), 139/152 1.12
(1.06–1.17)
NA





95.7 (92.4–99.1), 135/141 90.1 (85.3–94.9), 137/152 1.06
(1.00–1.13)
NA
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Glostrup. In patients with TIA, the acute and total hospital
stays were significantly shorter than in the matched contem-
porary cohort of patients with TIA. The length of the acute
stay was a median of 0.5 days vs 2 days. Mortality rates at day
30 and day 365 were comparable in the 2 TIA cohorts (0.0%
vs 0.0%; 2.0% vs 5.9%). All or none of 4 process performance
measures were higher in the patients with TIA from the
outpatient clinic cohort (96.7%) than in the contemporary
TIA patients (87.6%) (table 5).
Discussion
This prospective cohort study of patients seen in an outpatient
clinic for acute minor stroke and TIA using subsequent ad-
mission of high-risk patients shows that these patients have a
shorter hospital stay, lower rate of readmissions at 30 days, and
higher quality of care than patients in matched historic and
contemporary cohorts without a similar outpatient service.
Substantially reducing the length of hospital stay may have the
untoward consequence of increasing the overall readmission
rate, which is a frequently used measure of quality and
safety35,36 of care, although there is some controversy as to how
readmissions should be interpreted.37 However, we also ob-
served a lower rate of risk-adjusted readmissions within the first
30 days among patients with stroke in the outpatient clinic
cohort. This may be due to overall higher quality of care as
evidenced by a decline in the rate of recurrent vascular events
and other potential complications.38 Another driver of this
reduction could be the lesser risk of a hospital-acquired in-
fection.39 Furthermore, almost half of the patients with stroke
in the outpatient clinic cohort (without an inpatient course)
were offered a 7-day follow-up by telephone, which was not
standard in hospitalized stroke cohorts, and this initiative may
have prevented readmissions but also limits direct comparisons.
Readmission rates among these outpatients (with or without
7-day follow-up) were low and similar, indicating that the effect
on the results may have been inconsiderable.
Another potential concern with the shorter length of stay is
recurrent neurovascular events at home, the risk of which is
highest during the first days.1,12 Tominimize this problem, we
aimed to identify and hospitalize patients at high risk of re-
current episodes and hence extended their length of hospital
stay.14 To qualify the clinical decision to do so, we developed a
risk assessment tool using the ABCD2 score combined with
imaging26 and other essential risk factors for recurrent epi-
sodes. The ABCD2 score and the later addition of vessel
status and brain imaging were originally used to select patients
in need of rapid referral to a neurovascular specialist,40 but
here we used the tool to qualify the decision of need for
hospitalization. This approach seemed acceptable and safe as
the overall rate of recurrent vascular episodes in patients who
were treated in the outpatient clinic without admission was
low (0.9%), only 0.6% of low-risk patients, and the recurrence
rates were lower than previously reported.1,41,42
We were not able to calculate a reliable rate of recurrent stroke
in the hospitalized patients of the study cohort or in the ref-
erence cohorts as new events in the early phase are not regis-
tered in the DSR and we did not perform a 7-day follow-up.
The significantly higher fulfillment of process performance
measures in patients with minor stroke and TIA from the
outpatient clinic cohort within a defined time frame was
surprising. Although the exact driver of this remains unknown,
we speculate that it may stem from the standardized setup
with rapid asses to MRI, ultrasound, and specialist evaluation.
Considering all of the patients with a final diagnosis of stroke
and TIA from the entire stroke center at Aarhus University
Table 3 Differences in Lengths of Hospital Stay, All-Cause Bed Days, Readmissions, Mortality, and Process Performance
Measures in Outpatient Stroke Cohort 1 (OSC1) and the Matched Historic Stroke Cohort (HSC) (continued)
Bed days (in hospital)
Outpatient stroke 1 (OSC1), n = 191/215,
d, median (IQR)
Historic stroke (HSC), n = 191,
d, median (IQR)






94.7 (91.5–97.9), 179/189 91.1 (87.0–95.1), 173/190 1.04
(0.98–1.10)
NA
Indirect swallow test ≤2
daysd
96.8 (94.3–99.3), 183/189 88.7 (84.1–93.3), 165/186 1.09
(1.03–1.16)
NA
Direct swallow test ≤2
daysd
96.3 (93.5–99.0), 180/187 89.2 (84.8–93.7), 166/186 1.08
(1.02–1.14)
NA
Abbreviations: CI = confidence interval; HR = hazard ratio; IQR = interquartile range; LOSR = length of stay ratio; RR = risk ratio.
a Adjusted for age (continuous variable), stroke severity (Scandinavian Stroke Scale; continuous variable), living arrangements, previous strokes, diabetes,
atrial fibrillation, smoking, alcohol, and hypertension.
b All or none of the 10 process performance measures, defined as the proportion of minor stroke/TIA episodes where all eligible measures were fulfilled for
the individual patient.
c Opportunity-based score defined as the overall proportion of fulfilled relevant performance measures for each patient.
d Included in ball or none and in copportunity-based score.
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Table 4 Differences in Lengths of Hospital Stay, All-Cause Bed Days, Readmissions, Mortality, and Process Performance
Measures in Outpatient Stroke Cohort 2 (OSC2) and the Matched Contemporary Stroke Cohort (CSC)
Bed days (in hospital)
Outpatient stroke 2 (OSC2), n = 194/215,
d, median (IQR)



















Outpatient stroke 2 (OSC2), n = 194/215, %
(CI), n/total n










Admitted to stroke unit 3.5 (0.1–7.0), 4/113 NA NA NA
Outpatient course only 2.5 (−1.0-6.1), 2/79 NA NA NA




Admitted to stroke unit 25.7 (17.5–33.8), 29/113 NA NA NA
Outpatient course only 30.4 (20.0–40.7), 24/79 NA NA NA
Mortality
Outpatient stroke 2 (OSC2), n = 194/215, %
(CI), n/total n






30 days 0.0 (0.0–0.0), 0/194 0.0 (0.0–0.0), 0/194 NA NA






Outpatient stroke 2 (OSC2), n = 194/215,
% (CI), n/total n
Contemporary (CSC), n = 194,




















66.7 (28.2–105.1), 6/9 100.0 (100.0–100.0), 23/23 0.64
(0.40–1.01)
NA
Brain imaging (CT or MRI)
≤0 daysd
98.5 (96.7–100.2), 191/194 88.1 (83.5–92.7), 170/193 1.12
(1.06–1.18)
NA
Imaging of the carotids ≤4
daysd
99.4 (98.3–100.6), 172/173 96.8 (94.2–99.3), 179/185 1.03
(1.03–1.03)
NA





95.8 (92.5–99.1), 137/143 94.0 (89.7–98.4), 110/117 1.02
(0.96–1.08)
NA
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Hospital, approximately 16% of the patients with stroke and
34% of the patients with TIA went to the outpatient clinic in
the study period (based on reported patients in 2014 to DSR30),
but we were unable to investigate whether, according to the local
instruction, more patients were eligible for the outpatient clinic.
However, this is likely to have reduced costs per patient as shorter
acute hospital stays for patients with stroke reduce hospital costs
overall,43 and the outpatient setup is probably also more cost
effective.8,15,44 Furthermore, the reduction in the rate of read-
missions is likely to contribute further to cost reduction.45 Nev-
ertheless, tomake final conclusions on the financial implications, a
formal economic evaluation is needed.
Centralization of stroke services resulting in shorter hospital
stays is associated with high levels of patient and relative sat-
isfaction and we speculate that this outpatient setup similarly
led to increased satisfaction among patients and relatives.46
All patients with suspected acute minor stroke and TIA were
referred directly to the outpatient clinic for diagnostic workup
from emergency medical services and general practitioners. A
considerable number were given a non-neurovascular di-
agnosis (≈53%). A high rate of minor stroke and TIA mis-
diagnosis (≈60%) has been documented in nonspecialized
settings.47 The result of this is that patients forgo the benefits
of timely evaluation and early treatment initiation or are
treated unnecessarily. Direct referral saves many people from
the debilitating effects of misdiagnosis.47
An MRI scan of the brain was standard in the diagnostic
workup and could have contributed to the high rate of non-
neurovascular diagnoses, as MRI is more sensitive to acute
smaller ischemic lesions than a CT scan48 and helpful in
rejecting a stroke/TIA suspicion.
A strength of this study is that it included all patients seen in the
outpatient clinic for a period of 1 year and that a high rate of
approximately 90% of the patients with stroke or TIA were
available for comparison with thematched reference populations.
A limitation of the nonrandomized study design is that it
carries a risk of confounding, which might have affected the
length of hospital stay, all-cause bed days, rate of read-
missions, and mortality, but it is unlikely to have affected the
quality of care reflected in key process performance indicators
due to very explicit inclusion and exclusion criteria used for
these indicators. By matching the cohorts on essential criteria
and adjusting data, we minimized the risk of confounding.
Furthermore, we used 2 different reference cohorts to ex-
amine the effect, which strengthened the design.
The study period began 16 months after opening of the
outpatient clinic and hence the comparison with the historic
controls may be subject to confounding by an underlying
calendar time–related trend of improvements in stroke care.
We chose this study period because we aimed to examine the
fully implemented setup and therefore deliberately did not
include the period immediately after the launch of the re-
organization. Furthermore, historic controls for patients with
TIA were lacking, as registration of patients with TIA in the
DSR was not implemented until mid-2013.
The matched cohort from a contemporary period from
another hospital was not exposed to these general time
trends in care but was vulnerable to local differences be-
tween the hospitals that could potentially affect the results.
To minimize this risk, we used patients from a comparable
university hospital without an acute outpatient clinic in
a region that is sociodemographically and healthwise
fairly similar49 and with the same standards of stroke care
according to the DSR.30
A randomized controlled experiment where all self-reliant pa-
tients suspected of minor stroke and TIA were randomized to
either the outpatient clinic or direct hospitalization would have
minimized the risk of bias further andwould inmanyways be the
preferred design to study the outpatient setup. This was not an
option as the implementation of outpatient clinics was part of the
politically decided reorganization of the acute stroke services in
Table 4 Differences in Lengths of Hospital Stay, All-Cause Bed Days, Readmissions, Mortality, and Process Performance
Measures in Outpatient Stroke Cohort 2 (OSC2) and the Matched Contemporary Stroke Cohort (CSC) (continued)
Bed days (in hospital)
Outpatient stroke 2 (OSC2), n = 194/215,
d, median (IQR)






Indirect swallow test ≤2
daysd
96.9 (94.4–99.4), 186/192 84.9 (79.5–90.3), 146/172 1.14
(1.07–1.22)
NA
Direct swallow test ≤2
daysd
96.3 (93.6–99.0), 183/190 84.9 (79.4–90.4), 141/166 1.13
(1.06–1.22)
NA
Abbreviations: CI = confidence interval; HR = hazard ratio; IQR = interquartile range; LOSR = length of stay ratio; RR = risk ratio.
a Adjusted for age (continuous variable), stroke severity (Scandinavian Stroke Scale; continuous variable), living arrangements, previous strokes, diabetes,
atrial fibrillation, smoking, alcohol, and hypertension.
b All or none of the 10 process performancemeasures defined as the proportion ofminor stroke/TIA episodeswhere all eligiblemeasureswere fulfilled for the
individual patient.
c Opportunity-based score defined as the overall proportion of fulfilled relevant performance measures for each patient.
d Included in ball or none and in copportunity-based score.
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the CDR, and a real-world cohort study using matched cohorts
therefore became our design choice.50
Overall, the investigated acute outpatient clinic setup for
minor stroke and TIA was a hybrid model where special-
ized neurovascular clinicians diagnosed and assessed the
risk of recurrent vascular events to support triage for
subsequent admission to the stroke ward. The model was
beneficial in terms of reduced length of hospital stay,
higher quality of stroke care, and reduced 30-day read-
mission rates compared to historic and contemporary
controls. The triage appears safe with a low rate of re-
current vascular events within the first week after returning
home. The study was limited by the nonrandomized design
as differences among the study cohorts could affect the
comparisons.
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Table 5 Differences in Lengths of Hospital Stay, Mortality, and Process Performance Measures in the Outpatient TIA
Cohort (OTC) and the Matched Contemporary TIA Cohort (CTC)
Bed days (in hospital) OTC, n = 153/171, d, median (IQR) CTC, n = 153, d, median (IQR)
OTC vs CTC
LOSR (CI) LOSR, adjusteda
Acute stay 0.50 (0.50) 2.00 (2.00) 0.35 (0.29–0.43) 0.37 (0.30–0.45)
Total stay 0.50 (0.50) 2.00 (3.00) 0.36 (0.28–0.45) 0.37 (0.29–0.47)
Mortality OTC, n = 153/171, % (CI), n/total n CTC, n = 153, % (CI), n/total n
OTC vs CTC
HR (CI) HR, adjusteda
30 days 0.0 (0.0–0.0) 0/153 0.0 (0.0–0.0) 0/153 NA NA
365 days 2.0 (−0.3-4.2), 3/153 5.9 (2.1–9.7), 9/153 0.32 (0.09–1.19) 0.31 (0.06–1.62)
Process performance measures OTC, n = 153/171, % (CI), n/total n CTC, n = 153, % (CI), n/total n
OTC vs CTC
RR (CI) RR, adjusteda
All or noneb 96.7 (93.9–99.6), 148/153 87.6 (82.3–92.9), 134/153 1.10 (1.03–1.18) NA
Opportunity-based score (%)c 98.3 (96.7–99.8), 153/153 95.8 (93.9–97.6), 153/153 1.03 (0.99–1.07) NA
Antiplatelet therapy ≤2 daysd 98.5 (96.5–100.6), 134/136 100.0 (100.0–100.0), 129/129 0.98 (0.98–0.98) NA
Anticoagulation therapy ≤14 daysd 93.3 (79.0–107.6), 14/15 100.0 (100.0–100.0), 11/11 0.89 (0.78–1.02) NA
Brain imaging (CT or MRI) ≤ 0 daysd 97.4 (94.8–99.9), 149/153 89.3 (84.3–94.3), 134/150 1.09 (1.03–1.16) NA
Imaging of carotids ≤4 daysd 99.3 (97.9–100.7), 143/144 97.8 (95.4–100.3), 135/138 1.02 (1.02–1.02) NA
Abbreviations: CI = confidence interval; HR = hazard ratio; IQR = interquartile range; LOSR = length of stay ratio; RR = risk ratio.
a Adjusted for age (continuous variable), stroke severity (Scandinavian Stroke Scale; continuous variable), living arrangements, previous strokes, diabetes,
atrial fibrillation, smoking, alcohol, and hypertension.
b All or none of the 4 process performancemeasures defined as the proportion ofminor stroke/TIA episodeswhere all eligiblemeasures were fulfilled for the
individual patient.
c Opportunity-based score defined as the overall proportion of fulfilled relevant performance measures for each patient.
d Included in ball or none and in copportunity-based score.
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